young woman with primary pulmonary hypertension presented with
interstitial lung disease approximately 5 years after successful
treatment with IV prostacyclin. The pathology was consistent with
nonspecific interstitial pneumonitis and was unresponsive to steroids
and immunosuppressive medications. We speculate that further
cases of this syndrome may be reported as more patients are
living beyond 5 years with prostacyclin.